Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...

The Delaware hearings are viewed as the greatest near-term chance that the class actions against ranitidine manufacturers will be revived, and whether GSK may consider additional settlements.

Class action and personal injury lawsuits have been filed in US courts after the Food and Drug Administration warned in 2019 that some ranitidine drugs including Zantac contained low levels of an ...

It is also facing a class action suit alleging economic injury ... business - although it says it is not a party to any of the Zantac claims. Meanwhile, Sanofi, Pfizer and Boehringer Ingelheim ...

GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits that alleged its discontinued heartburn drug Zantac caused cancer.

Rosenberg dismissed every Zantac lawsuit filed in the multidistrict litigation class in December 2022, said Miller & Zois Attorneys at Law. That still left cases in state courts. The Financial ...

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug. GSK suffered ...

The Zantac dispute stems from 2019 ... legal claims relating to alleged privacy breaches in the Netherlands. The class action claims are currently subject to an appeal. TikTok, owned by Beijing ...